Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19

Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19

The coronavirus disease 2019 (COVID-19) has become a substantial threat to the international health sector and the global economy. As of 26 December 2021, the number of mortalities resulting from COVID-19 exceeded 5.3 million worldwide. The absence of an effective non-vaccine treatment has prompted...

Full description

Bibliographic Details
Main Authors: Hendris Wongso, Isa Mahendra, Wyanda Arnafia, Idar Idar, Muhammad Yusuf, Arifudin Achmad, Holis A. Holik, Ahmad Kurniawan, Iim Halimah, Maula E. Sriyani, Teguh H. A. Wibawa, Muhamad B. Febrian, Yanuar Setiadi, Eva M. Widyasari, Isti Daruwati, Crhisterra E. Kusumaningrum, Toto Subroto
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Vaccines
Subjects:
IgY anti-RBD spike SARS-CoV-2
passive immunization
COVID-19
preclinical evaluation
radiolabeled IgY
Online Access:https://www.mdpi.com/2076-393X/10/1/128

Internet

https://www.mdpi.com/2076-393X/10/1/128

Similar Items